Navigation Links
Versus Technology Announces First Quarter Results
Date:2/27/2008

TRAVERSE CITY, Mich., Feb. 27 /PRNewswire-FirstCall/ -- Versus Technology, Inc. ("Versus" or the "Company") announced revenues of $1,426,000 for its first fiscal quarter ended January 31, 2008, a 26% increase over revenues of $1,133,000 for the same quarter of the prior year. Versus' quarterly revenues can vary significantly depending upon the timing of delivery of major customer projects. Accordingly, the revenues reported in any one quarter are not necessarily indicative of what full year results will be.

Gross profits as a percentage of revenues were 71% for the current year's first quarter compared to 61% for the same quarter of the prior year. Operating expenses, other than cost of revenues, increased 27% for the current year's first quarter compared to the same quarter of the prior year, primarily due to an increase in sales and marketing expenses.

Versus reported a net loss of $130,000 for the current year's first quarter compared to a net loss of $212,000 for the same quarter of the prior year. The decrease in cash from the balance at October 31, 2007, was due in part to capital spending on facilities to accommodate expansion of the organization.

For additional information, please refer to the attached unaudited consolidated financial statements.

Versus Technology, Inc. (Pink Sheets: VSTI.PK) (http://www.versustech.com) (Versus) is the leader in the development and sale of context-aware systems used for the management of patient flow and medical assets and to improve caregiver/patient communications in medical and long-term care facilities. Versus also supplies Active RFID/IR tags and readers that make locating systems more precise, security systems more intelligent, data collection routines automatic, and asset management systems more efficient. Versus' systems, which are currently installed in hospitals, corporate facilities, government facilities, and other complexes,
'/>"/>

SOURCE Versus Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Occlutech Wins Confirmation of its Intellectual Property Position Versus AGA Medical Patent by AIPPI
2. Smart Home Cleaning: New Web Site Educates Consumers on Looking Clean Versus Being Clean
3. Versus Technology Announces Fourth Quarter Results
4. DuPont Strengthens Leading Biotechnology Position with Leadership Changes
5. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
6. Federal toxics disclosure law could help inform public of nanotechnology risks
7. The Quantum Group Announces Strategic Technology Alliance
8. Balfour Resource Group Announces Ryan Frymire as Director of Technology Planning
9. MedPlus Technology Driving Three New York Health Information Exchanges
10. Spending on Healthcare Information Technology Inches Up
11. Perot Systems and Oakwood Healthcare Deliver Advanced Technology & Revenue Cycle Solutions to Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)...10 don,t do enough to protect themselves from stro...HealthDay News) -- It,s one of medicine,s mantras:...lower it will have a dramatic impact on your risk ...cent of people with high blood pressure still aren...ng to a U.S. Centers for Disease Control and Preve...
(Date:11/21/2008)...UNTY, Calif., Nov. 21 Album Creati...irm, launches a new program offering big brand mar...aken the large, expensive ad agency process and se... a very hands-on approach," says Matt Parker, Crea... combines experience and proven brand-building tec...
(Date:11/21/2008)...HASSEE, Fla. -- A Florida State University College...s discovered an important new layer of regulation ...greater understanding of the way cancer begins. ,...ces at the College of Medicine, said the findings ...r and could lead to the design of new drugs that k...
(Date:11/21/2008)...riz., Nov. 21 The Provid...announced that Craig A. Norris, the Company,s,Chi...mpany,s Board of,Directors. Mr. Norris, appointm...gnation of Steven I. Geringer and returns the boar...ny committee of the Board. , Mr. Norris, ag...
Breaking Medicine News(10 mins):Health News:High Blood Pressure Stalks Many Americans 2Health News:High Blood Pressure Stalks Many Americans 3Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3
...nt positive side too, a study now reports. Bad gos...the study says that it may create or increase inti...in the June issue of the journal Personal Relation...egative attitudes that are frequently shared among...
...p of leading global health experts have come toget...ional donors// to negotiate affordable pricing of ...s of developing world countries and their partners...works and begin preparations for pneumococcal vacc...
...g of the American Society of Hypertension in New Y...e sexual dysfunction// (FSD) and high blood pressu...women with increased hypertension and increased ag...defined as persistent or recurring decrease in sex...
...brand new internet-based television show//: Pharma...PharmaVentures, says, ‘This show, the first in a m...eutical and biotechnology sectors with insightful ... transactions and industry trends. It gives exclus...
Other Medicine News:Health News:Intro of Pneumococcal Vaccines: Experts Urge Commitment From Industry 2Health News:Intro of Pneumococcal Vaccines: Experts Urge Commitment From Industry 3Health News:Link Established Between FSD and High Blood Pressure 2Health News:PharmaVentures Exploits Fastest Growing Media Channel to Launch First Pharmaceutical Business Television Show 2
(Date:11/21/2008)...rstCall/ -- Amgen,(Nasdaq: AMGN ) today announc...ucts for Human Use (CHMP) has issued a positive op...late(TM) (romiplostim) in the European Union,(EU)...mune (idiopathic),thrombocytopenia purpura (ITP) ...er treatments (e.g. corticosteroids, immunoglobuli...
(Date:11/20/2008)...w Jersey American Water has lifted the precaution...following municipalities in Middlesex, Somerset an... , , Dunellen , Edison , ...nfield , , , , Somerset County , ..., Green Brook , Hillsborough , ...
(Date:11/20/2008)...Call/ -- Bionovo, Inc.,(Nasdaq: BNVI ) announce...1B,clinical trial of their lead drug candidate fo...he Society for Integrative Oncology,s Fifth Intern...any,s oral presentation was selected,as a top sco...he Best of the,SIO Session on November 20, 2008. ...
(Date:11/20/2008)...-- The Scandinavian-based drug,development compan... on its,lead antimicrobial candidate LTX-109. Pre...owed that the novel lytic peptidomimetic has an ul...ter towards killing Staphylococcus,aureus and Str...ugs. In,addition to this it has proven effective ...
Breaking Medicine Technology:Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 2Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 3Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 4Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 5Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 7Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 8New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2NanoLogix Inc Presents at the National Hydrogen Association Conference 26 Provides Operations Management and Director Update 4275 1NanoLogix Inc Presents at the National Hydrogen Association Conference 26 Provides Operations Management and Director Update 4275 2NanoLogix Inc Presents at the National Hydrogen Association Conference 26 Provides Operations Management and Director Update 4275 3Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 1Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 2Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 3Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 4Study finds support for PCI in unprotected left main disease 15501 1Study finds support for PCI in unprotected left main disease 15501 2Study finds support for PCI in unprotected left main disease 15501 3Milestone Scientific Announces 2007 Year End Results 15497 1Milestone Scientific Announces 2007 Year End Results 15497 2Milestone Scientific Announces 2007 Year End Results 15497 3Milestone Scientific Announces 2007 Year End Results 15497 4Milestone Scientific Announces 2007 Year End Results 15497 5Milestone Scientific Announces 2007 Year End Results 15497 6Milestone Scientific Announces 2007 Year End Results 15497 7
Triad Plus Sterile Isopropyl Alcohol 70% USP Swabsticks are primarily used as a topical antiseptic prior to administering injections. They are gamma sterilized to meet AAMI/ANSI/ISO 11137 standar
...-I Prep Swabsticks are saturated with a 10% Po...vailable iodine. Povidone Iodine is virtually non-...is also non-staining to the skin or natural fabric...t; they are sturdy tools for removing small partic...
Aplicare's Saturated Swabsticks are packaged in easy open, single-use foil-laminated pouches. Each 4 inch Swabstick is saturated with precisely the correct amount of solution. Each package is termina
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness.
Medicine Products: